Evidence map›Paper›PMID 26329039›Full record

ArticleScientific reports2015

Phosphoproteomic profiling of tumor tissues identifies HSP27 Ser82 phosphorylation as a robust marker of early ischemia.

Muhammad Saddiq Zahari, Xinyan Wu, Sneha M Pinto, Raja Sekhar Nirujogi, Min-Sik Kim, Barry Fetics, Mathew Philip, Sheri R Barnes, Beverly Godfrey, Edward Gabrielson and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2020
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Muhammad Saddiq ZahariMcKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA.
Xinyan WuMcKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA.
Sneha M PintoInstitute of Bioinformatics, International Tech Park, Bangalore, 560066 India.
Raja Sekhar NirujogiInstitute of Bioinformatics, International Tech Park, Bangalore, 560066 India.
Min-Sik KimMcKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA.
Barry FeticsRobin Medical, Inc., P.O. Box 2414, Baltimore, MD 21203, USA.
Mathew PhilipRobin Medical, Inc., P.O. Box 2414, Baltimore, MD 21203, USA.
Sheri R BarnesCharles River Discovery Research Services, 3300 Gateway Centre Boulevard, Morrisville NC 27560.
Beverly GodfreyCharles River Discovery Research Services, 3300 Gateway Centre Boulevard, Morrisville NC 27560.
Edward GabrielsonDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA.
Erez NevoRobin Medical, Inc., P.O. Box 2414, Baltimore, MD 21203, USA.
Akhilesh PandeyMcKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA.
Johns Hopkins Medicine · USRobin Medical (United States) · USCharles River Associates · USInstitute of Bioinformatics · INJohns Hopkins University · US

Funding

Proteome Characterization Center: A Genoproteomics Pipeline for Cance ResearchU24CA160036 · NCI · JOHNS HOPKINS UNIVERSITY · PI CHAN, DANIEL WANYUI, ZHANG, HUI · 2011 to 2016
$10.7M
Networks, Pathways and Dynamics of Lysine ModificationU54GM103520 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI BADER, JOEL S. · 2012 to 2013
$7.0M
NCI NIH HHS U24 CA160036NCI NIH HHS U24CA160036NHLBI NIH HHS HHSN268201000032CNIGMS NIH HHS U54 GM103520NIGMS NIH HHS U54GM103520PHS HHS HHSN268201000032C
6 · The paper itself

Abstract

Delays between tissue collection and tissue fixation result in ischemia and ischemia-associated changes in protein phosphorylation levels, which can misguide the examination of signaling pathway status. To identify a biomarker that serves as a reliable indicator of ischemic changes that tumor tissues undergo, we subjected harvested xenograft tumors to room temperature for 0, 2, 10 and 30 minutes before freezing in liquid nitrogen. Multiplex TMT-labeling was conducted to achieve precise quantitation, followed by TiO2 phosphopeptide enrichment and high resolution mass spectrometry profiling. LC-MS/MS analyses revealed phosphorylation level changes of a number of phosphosites in the ischemic samples. The phosphorylation of one of these sites, S82 of the heat shock protein 27 kDa (HSP27), was especially abundant and consistently upregulated in tissues with delays in freezing as short as 2 minutes. In order to eliminate effects of ischemia, we employed a novel cryogenic biopsy device which begins freezing tissues in situ before they are excised. Using this device, we showed that the upregulation of phosphorylation of S82 on HSP27 was abrogated. We thus demonstrate that our cryogenic biopsy device can eliminate ischemia-induced phosphoproteome alterations, and measurements of S82 on HSP27 can be used as a robust marker of ischemia in tissues.

Indexed as

AnimalsBiomarkersBiopsyCell Line, TumorHSP27 Heat-Shock ProteinsHumansIschemiaMice, SCIDPhosphoproteinsPhosphorylationPhosphoserineProteomicsUp-RegulationXenograft Model Antitumor AssaysBiomarkersHSP27 Heat-Shock ProteinsPhosphoproteinsPhosphoserine

Identifiers

PMID26329039
PMCPMC4557083
OpenAlexW2433623718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.